NCT00117377View on ClinicalTrials.gov

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

June 30, 2005

Conditions

Atopic Dermatitis

Interventions

DRUG

Pimecrolimus

Pimecrolimus cream 1 % bid

DRUG

Placebo

Placebo application bid

Trial Locations (3)

Unknown

Mount Sinai School of Medicine, New York

New York University Hospital, New York

Virginia Clinical Research, Inc, Norfolk

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY